| Jessie Joann Kruse, PHARMD | |
|
1204 Se 28th St Ste 2, Bentonville, AR 72712-3887 | |
| (888) 414-5805 | |
| (855) 422-2400 |
| Full Name | Jessie Joann Kruse |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1204 Se 28th St Ste 2, Bentonville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013697440 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2018024612 (Missouri) | Secondary |
| 183500000X | Pharmacist | 21320 (Nevada) | Secondary |
| 183500000X | Pharmacist | PD14624 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessie Joann Kruse, PHARMD Po Box 359, Bentonville, AR 72712-0359 Ph: (417) 840-8838 | Jessie Joann Kruse, PHARMD 1204 Se 28th St Ste 2, Bentonville, AR 72712-3887 Ph: (888) 414-5805 |
News Archive
According to researchers at the National Heart, Lung, and Blood Institute (NHLBI), increasing the dose of niacin to patients with heart disease who are already taking a cholesterol-lowering statin does nothing extra to prevent heart attacks and strokes. Approximately one out of seven Americans have high blood cholesterol, a main risk factor in heart disease, which kills some 800,000 people in the United States annually.
Over-production of nitric oxide and ion disturbance are involved in neuronal apoptosis around the ischemic area following ischemic brain injury. Prof. Quanzhong Chang and team from Zhuhai Campus of Zunyi Medical College in China established a rat model of hippocampal neuronal apoptosis by using 3-morpholinosyndnomine (SIN-1), a nitric oxide donor.
Orexigen® Therapeutics, Inc. and Takeda Pharmaceutical Company Limited announced today that the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 13 to 7 that the available data adequately demonstrate that the potential benefits of Contrave® (naltrexone sustained release (SR)/bupropion SR) outweigh the potential risks when used long-term in a population of overweight and obese individuals and support approval.
Oncolytics Biotech Inc. announced today that a paper entitled "Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice," co-senior authored by Dr. Richard Vile of the Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA, and Dr. Kevin Harrington of the Institute of Cancer Research, London, UK, was published in the online version of the Journal of Clinical Investigation on April 1, 2010.
Sexuality and religion are generally considered uncomfortable bedfellows. Now, for the first time, a team of researchers from Nottingham have carried out a detailed study around these issues and how they affect and influence the lives of British 18 to 25 year olds.
› Verified 2 days ago
Michael Fertig, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2730 Sw Livingston Sq, Bentonville, AR 72713 Phone: 214-578-3685 | |
Darren Keith Townzen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 702 Sw 8th St, Bentonville, AR 72712 Phone: 479-381-6136 | |
Rane Dearing, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3510 Se 14th St, Bentonville, AR 72712 Phone: 479-621-6470 Fax: 479-621-6461 | |
Pierce Wyland Skersick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2805 Mid Cities Dr, Bentonville, AR 72712 Phone: 479-271-7634 | |
Tatum Bishop, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3510 Se 14th St, Bentonville, AR 72712 Phone: 479-621-9470 | |
Mr. Kirk Eugene Milam, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 316 Nw Lasalle Dr, Bentonville, AR 72712 Phone: 479-271-9007 |